NetworkNewsBreaks – Pivot Pharmaceuticals Inc. (
Post# of 52
Pivot Pharmaceuticals (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) is engaged in the development and commercialization of quality cannabinoid-based nutraceuticals and pharmaceuticals by utilizing unique drug delivery platform technologies. An article discussing the company reads: “Pivot Pharmaceuticals has a suite of 30 products ready for commercialization. The company also has a strong intellectual property (“IP”) portfolio for the formulation and delivery of cannabinoids. Pivot’s proposed product line comprises capsules and tablets, bulk powder, stick packs and beverages. Its product line also consists of water soluble oral solutions, lotions, creams, gels and pet supplements. … Pivot Pharmaceuticals has acquired the global rights for four proprietary drug delivery technologies. These technologies are for the delivery and commercialization of cannabinoid-, cannabidiol- and tetrahydrocannabinol-based products.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer